MedPath

Effect of using sweetener sucralose for 12 weeks on body weight, glycemic and lipid parameters among adults with diabetes in India

Not Applicable
Registration Number
CTRI/2021/04/032686
Lead Sponsor
Madras Diabetes Research Foundation
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

.Adults with type 2 diabetes and BMI greater than 18.5

.Hba1c 8-12%

.Individuals on stable OHA/insulin dose

.Willing to follow study protocol

.Willing to give informed consent

.Willing to use LCS-sucralose for 12 weeks

Exclusion Criteria

.Any acute infections like viral fever, typhoid, cold, diarrhea, constipation last 1 month

.Individuals with any disorders of liver, kidney, thyroid, or other endocrine diseases or other complications such as respiratory disorders, diabetes, cancer or heart attack and stroke that hinders the intervention

.Individuals with any eating disorder

.Participants undergoing any treatment or medications including antibiotics

.Pregnant and lactating Women

.Plans to relocate in the next 3 years.

.Planning longer duration of travel out of town

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath